Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hospira, a provider of injectable drugs has launched imipenem-cilastatin for injection, I.V. in the US.
Subscribe to our email newsletter
Imipenem-cilastatin, a generic version of Merck’s Primaxin is a carbapenem that belongs to the beta-lactam class of antibiotics.
The medication will be made available in 250 mg and 500 mg flip-top vials.
Hospira Specialty Pharmaceuticals vice president/general manager Joshua Gordon said the company is committed to providing generic alternatives in this category of antibiotics and imipenem-cilastatin is their second carbapenem in the US.
"Hospira is committed to continuing to reduce the cost of healthcare by providing savings with first-to-market generic injectables," Gordon added.